Delivery Order SPE2DR25D9133-SPE2DR26FCFR2
- Not listed
- The Defense Logistics Agency awarded a $16,900.92 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit 6ml. The delivery order, which carries an ultimate completion date of January 7, 2026, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $11,267.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit 6ml. The contract, designated as delivery order 4570008681, carries a firm fixed-price structure with no set-aside designation and an ultimate completion date of December 2, 2025. This delivery order was issued under DMS Pharmaceutical Group's recently...
- The Defense Logistics Agency awarded a $18,404.70 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for the supply of Photrexa Cross-Linking Kit 6ml, with an ultimate completion date of February 11, 2026. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating its competitive capability in unrestricted federal procurement. This delivery order is issued...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $11,182.53 to DMS Pharmaceutical Group Inc. for the supply of Photrexa Cross-Linking Kit (6ml). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this order at its Park Ridge facility, with an ultimate completion date of September 24, 2025. This delivery order was issued without a set-aside designation and represents one of many...
- The Defense Logistics Agency issued a $11,267.28 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit 6ML. The award, issued on November 17, 2025, with an ultimate completion date of December 9, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,067.45 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit 6ml. The delivery order, issued on January 13, 2026, with an ultimate completion date of February 4, 2026, carries no set-aside designation, indicating the award was made through unrestricted federal procurement. This delivery order is issued...
- The Defense Logistics Agency awarded a $12,269.80 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit 6ML. The delivery order, issued on January 20, 2026, with an ultimate completion date of February 10, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award is issued...
- The Defense Logistics Agency awarded a delivery order valued at $22,534.56 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit (6ml). The award, issued on October 31, 2025, with an ultimate completion date of November 24, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating the contractor competed in the open market. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $22,365.06 to DMS Pharmaceutical Group Inc. for the supply of Photrexa Cross-Linking Kit 6ML, with an ultimate completion date of October 7, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this work at its Park Ridge facility. This delivery order represents a firm fixed-price contract with no set-aside designation, issued under the company's...
- The Defense Logistics Agency awarded a $18,637.55 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 3, 2025, for the supply of Photrexa Cross-Linking Kit 6ML, with an ultimate completion date of September 24, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The company will perform this delivery order at its Park Ridge, IL location, continuing its...
- SPE2DR25D9133Indefinite Delivery Contract
- SPE2DR25D9133-SPE2DR26FCFR2Delivery Order
The Defense Logistics Agency awarded a $12,269.80 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for the Photrexa Cross-Linking Kit (6mL), with an ultimate completion date of February 20, 2026. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The delivery order will be performed at the contractor's Park Ridge facility and represents a continuation of the company's substantial pharmaceutical supply activity supporting Department of Defense operations. This delivery order was issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion federal acquisition strategy. The underlying IDC, valued at $499,999,999 with a completion date of December 31, 2036, authorizes DLA to issue delivery orders for branded and generic pharmaceuticals, biologics, and medical consumables to support military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance on numerous previous delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the Department of Defense healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.3k | 1/28/26 |